{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:34:39Z","timestamp":1779204879359,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.drugalcdep.2015.08.007","type":"journal-article","created":{"date-parts":[[2015,8,15]],"date-time":"2015-08-15T13:30:17Z","timestamp":1439645417000},"page":"298-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Buprenorphine infrequently found in fatal overdose in New York City"],"prefix":"10.1016","volume":"155","author":[{"given":"Denise","family":"Paone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellenie","family":"Tuazon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Stajic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bennett","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivani","family":"Mantha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillary","family":"Kunins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0005","series-title":"Advancing Access to Addiction Medications: Implications for Opioid Addiction Treatment","author":"American Society of Addiction Medicine","year":"2013"},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0010","series-title":"The Standards of Care for the Addiction Specialist Physician","author":"American Society of Addiction Medicine","year":"2014"},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jama.285.1.39","article-title":"Deaths attributable to methadone vs buprenorphine in France","volume":"285","author":"Auriacombe","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ADM.0b013e3182034e31","article-title":"Illicit use of buprenorphine\/naloxone among injecting and noninjecting opioid users","volume":"5","author":"Bazazi","year":"2011","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0025","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1360-0443.2009.02627.x","article-title":"Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment","volume":"104","author":"Bell","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.drugalcdep.2014.12.002","article-title":"Illicit use of opioid substitution drugs: prevalence, user characteristics, and the association with non-fatal overdoses","volume":"147","author":"Bretteville-Jensen","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0035","series-title":"The Plain Dealer","article-title":"Suboxone, an addiction treatment drug, seeps into Ohio prisons as contraband","author":"Caniglia","year":"2013"},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0040","doi-asserted-by":"crossref","first-page":"302","DOI":"10.5055\/jom.2007.0018","article-title":"Use and misuse of buprenorphine in the management of opioid addiction","volume":"3","author":"Cicero","year":"2007","journal-title":"J. Opioid Manag."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0045","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jamainternmed.2013.9059","article-title":"Responses of state Medicaid programs to buprenorphine diversion: doing more harm than good?","volume":"173","author":"Clark","year":"2013","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0055","first-page":"37","article-title":"Update on the clinical use of buprenorphine: in opioid-related disorders","volume":"58","author":"Ducharme","year":"2012","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0060","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/jamainternmed.2014.5302","article-title":"Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial","volume":"174","author":"Fiellin","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0065","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jsat.2014.07.015","article-title":"Illicit buprenorphine use, interest in and access to buprenorphine treatment among syringe exchange participants","volume":"48","author":"Fox","year":"2015","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/10550887.2012.759860","article-title":"Suboxone misuse along the opiate maintenance treatment pathway","volume":"32","author":"Furst","year":"2013","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0075","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/j.addbeh.2013.08.008","article-title":"Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland","volume":"38","author":"Genberg","year":"2013","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0080","series-title":"The Daily Beast","article-title":"This anti-heroin drug is now king of the jailhouse drug trade","author":"Genis","year":"2014"},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0085","first-page":"A1","article-title":"When children's scribbles hide a prison drug","author":"Goodnough","year":"2011","journal-title":"N.Y. Times"},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0090","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3109\/10550490903077820","article-title":"Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland","volume":"18","author":"Gwin Mitchell","year":"2009","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0095","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00228-011-1122-4","article-title":"Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning","volume":"68","author":"H\u00e4kkinen","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.forsciint.2014.10.028","article-title":"Prescription opioid abuse based on representative postmortem toxicology","volume":"245C","author":"H\u00e4kkinen","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0105","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1542\/peds.2007-1774","article-title":"Toxicity of buprenorphine overdoses in children","volume":"121","author":"Hayes","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0115","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/02791072.2014.960109","article-title":"Diversion of methadone and buprenorphine from opioid substitution treatment: a staff perspective","volume":"46","author":"Johnson","year":"2014","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0120","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(03)12600-1","article-title":"1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial","volume":"361","author":"Kakko","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0125","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0379-0738(01)00454-6","article-title":"Deaths involving buprenorphine: a compendium of French cases","volume":"121","author":"Kintz","year":"2001","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0130","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/ADM.0b013e3182312983","article-title":"Statement of the American Society of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction","volume":"5","author":"Kraus","year":"2011","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0135","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2217\/pmt.12.26","article-title":"Buprenorphine implant for opioid addiction","volume":"2","author":"Ling","year":"2012","journal-title":"Pain Manage."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0140","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.drugalcdep.2012.05.025","article-title":"Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine","volume":"126","author":"Lofwall","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0145","series-title":"Al Jazeera America","article-title":"Heroin epidemic gives rise to a generation of \u2018Suboxone babies\u2019","author":"May","year":"2014"},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0150","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0002-9343(98)00194-6","article-title":"A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic","volume":"105","author":"O\u2019Connor","year":"1998","journal-title":"Am. J. Med."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0155","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00003495-200969050-00006","article-title":"Buprenorphine\/naloxone: a review of its use in the treatment of opioid dependence","volume":"69","author":"Orman","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0160","series-title":"113th Cong., 2013\u20132014","author":"Recovery Enhancement for Addiction Treatment Act of 2014, S. 2645","year":"2014"},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0165","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jsat.2007.05.009","article-title":"Nurse practitioner and physician assistant interest in prescribing buprenorphine","volume":"34","author":"Roose","year":"2008","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsat.2010.03.014","article-title":"Self-treatment: illicit buprenorphine use by opioid-dependent treatment seekers","volume":"39","author":"Schuman-Olivier","year":"2010","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0175","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.forsciint.2012.03.016","article-title":"Toxicological and pathological findings in a series of buprenorphine related deaths, possible risk factors for fatal outcome","volume":"220","author":"Selden","year":"2012","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0180","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jsat.2014.07.010","article-title":"Supply of buprenorphine waivered physicians: the influence of state policies","volume":"48","author":"Stein","year":"2015","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0185","first-page":"A1","article-title":"Addiction treatment with a dark side","author":"Sontag","year":"2013","journal-title":"N.Y. Times"},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0190","series-title":"The DAWN Report: Emergency Department Visits Involving Buprenorphine","author":"Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality","year":"2013"},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0195","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/dar.12143","article-title":"Opioid-related mortality and filled prescriptions for buprenorphine and methadone","volume":"33","author":"Wikner","year":"2014","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0200","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/10550887.2011.642757","article-title":"The emerging buprenorphine epidemic in the United States","volume":"31","author":"Wish","year":"2012","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0205","series-title":"Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence","author":"World Health Organization","year":"2009"},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0210","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1521-0391.2012.00335.x","article-title":"Steps physicians report taking to reduce diversion of buprenorphine","volume":"22","author":"Yang","year":"2013","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2015.08.007_bib0215","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874473711104010028","article-title":"Buprenorphine and buprenorphine\/naloxone diversion, misuse, and illicit use: an international review","volume":"4","author":"Yokell","year":"2011","journal-title":"Curr. Drug Abuse Rev."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871615015987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871615015987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T08:00:08Z","timestamp":1567065608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871615015987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":41,"alternative-id":["S0376871615015987"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.08.007","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Buprenorphine infrequently found in fatal overdose in New York City","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}